Skip to main content
. 2018 Sep 7;38(5):BSR20171459. doi: 10.1042/BSR20171459

Figure 9. Ruboxistaurin inhibits PKC βII mediated downregulation of VEGF dependent Akt/eNOS pathway.

Figure 9

Western blot analysis showing protein expression level of p-Akt over total Akt (A,B), p-eNOS over total (eNOS) (A,C) and total VEGF over total GAPDH (A,D), in wounds 12 days post-wounding. **P<0.01 compared with Control; #P<0.05 compared with STZ. The data are expressed as the means ± S.E.M. (n=10 per group).